|Treatments:||Chemotherapy||Hospital:||UPMC Université Paris|
This study involved 207 patients with untreated Waldenstrom macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma. The median patient age was 67.8 years and 67% were male.
Patients were treated with the chemotherapy agent called chlorambucil.
Four treatment-related deaths due to infection were reported. Grade 4 neutropenia, liver enzyme abnormalities, and lung toxicity were also reported.
The median overall survival was 69.8 months.
This study was supported by Schering and Bayer Pharmaceuticals.
Correspondence: Dr. Veronique Leblond; email: Veronique.email@example.com